ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Rigel Finalizes Study Design of Fostamatinib Trial for Warm Autoimmune Hemolytic Anemia
December 01, 2020Rigel Pharmaceuticals has reached agreement with the U.S. Food and Drug Administration (FDA) on the final design of its FORWARD study, a pivotal Phase 3 clinical trial of fostamatinib disodium hexahydrate (fostamatinib) in warm autoimmune hemolytic ...
Pharma Sources Insight January 2025
